Mario Romano

Department of Medical, “G. d’Annunzio” University of Chieti-Pescara

Affiliated with“G. d’Annunzio” University of Chieti-Pescara

Research Area

Biography

Mario Romano has not added Biography.
If you are Mario Romano and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 3	2023

Other Publications

Article	Year
5-lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor. FASEB journal : official publication of the Federation of American Societies for Experimental Biology\| PubMed ID: 11689458	2001
Urinary excretion of lipoxin A(4) and related compounds: development of new extraction techniques for lipoxins. Laboratory investigation; a journal of technical methods and pathology\| PubMed ID: 12218086	2002
Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. FASEB journal : official publication of the Federation of American Societies for Experimental Biology\| PubMed ID: 14597668	2003
Lipoxin analogs and lipoxin formation in vivo. Prostaglandins, leukotrienes, and essential fatty acids\| PubMed ID: 15979293	2005
Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins. Inflammation & allergy drug targets\| PubMed ID: 16613567	2006
Lipoxin receptors. TheScientificWorldJournal\| PubMed ID: 17767357	2007
Lipoxin and aspirin-triggered lipoxins. TheScientificWorldJournal\| PubMed ID: 20526535	2010
MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages. The Journal of biological chemistry\| PubMed ID: 25505240	2015
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation. European journal of pharmacology\| PubMed ID: 25895638	2015
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins. Stem cells translational medicine\| PubMed ID: 26607175	2016
Epigenetic regulation of the formyl peptide receptor 2 gene. Biochimica et biophysica acta\| PubMed ID: 27424221	2016
Immobilization and delivery of biologically active Lipoxin A using electrospinning technology. International journal of pharmaceutics\| PubMed ID: 27732897	2016
Lipoxin A stimulates endothelial miR-126-5p expression and its transfer microvesicles. FASEB journal : official publication of the Federation of American Societies for Experimental Biology\| PubMed ID: 28100645	2017
Establishment and long-term culture of human cystic fibrosis endothelial cells. Laboratory investigation; a journal of technical methods and pathology\| PubMed ID: 28759010	2017
Mechanisms of endothelial cell dysfunction in cystic fibrosis. Biochimica et biophysica acta. Molecular basis of disease\| PubMed ID: 28847515	2017
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. Scientific reports\| PubMed ID: 29044225	2017
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review. Stem cells translational medicine\| PubMed ID: 31187940	2019
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis. Frontiers in immunology\| PubMed ID: 32528461	2020
The Resolution Approach to Cystic Fibrosis Inflammation. Frontiers in pharmacology\| PubMed ID: 32848748	2020
Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis. Frontiers in pharmacology\| PubMed ID: 34566635	2021
Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society\| PubMed ID: 34799298	2022
CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells. Cells\| PubMed ID: 35456026	2022
3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics. International journal of molecular sciences\| PubMed ID: 36077471	2022